The roach control company Greenix pesto is making national headlines this week after an internal report said that it had not made a profit in the last six months of operation.
The company, which was founded by two former Wall Street traders, has been embroiled in controversy since its inception.
Greenix was founded in 2007 to help businesses cope with the arrival of roach infestations.
“We don’t know if the numbers are there, but we don’t see a lot of activity,” Greenix spokesman Chris Lohmer told The Hill.
When it came to the company’s financial statements, Greenix had not provided financial information to investors.
Greenix also did not provide any sales or operating data, which is required by federal law.
Its sales have declined from $10.4 million in September to $2.8 million, according to an annual report.
However, Greenux has a good track record of operating, according a review of its financials by Business Insider.
In the year ended June 30, 2015, the company made a loss of $9.8 milion, or 8.9 percent.
GreenIX’s first quarter revenue was $2 million, up from $1.7 million in the same quarter of 2015.
It also reported operating income of $2,074, or 13.7 percent, down from $5.9 million in its second quarter of the year.
Its revenue increased from $8.9 to $10 million.
But it also reported a loss from operations of $1,979, or 10.7, a decline of 5.9 percentage points.
Greenux has faced criticism from the public and from regulators.
At least 14 states and the District of Columbia have taken action against Greenix, saying it is not a pest control company and is operating in violation of federal law, including the Food, Drug, and Cosmetic Act.
Some states have already filed lawsuits against the company, claiming it is operating a commercial business and is profiting from its presence in the marketplace.
A number of states, including Washington, Vermont and New York, have also introduced laws to protect people and businesses from the roaches that are invading our homes and businesses.
Greenx is not the only pest control firm to face scrutiny.
The Washington Post reported that the company has been caught selling products that have not been tested for their safety.
The company has also faced accusations of overcharging consumers for their services.
The Post reported on Wednesday that Greenix has been accused of offering more than $100,000 to people who are sick or have compromised immune systems.
GreenX did not respond to a request for comment.